Andrx To Pay $6M To Settle Kos Trademark Suit

Law360, New York (June 10, 2004, 12:00 AM EDT) -- Andrx Corp. will pay Kos Pharmaceuticals $6 million and agree to stop using the Altocor trademark for any of its products under a settlement agreement between the two companies.

Kos said the payment and promise settle a trademark infringement lawsuit and should avoid further confusion between Andrx's cholesterol product, Altocor, and Kos' cholesterol product, Advicor.

Last month, an appeals court ordered a lower court to grant Kos Pharmaceuticals’ request for an injunction against Andrx’s use of the brand name "Altocor" in order to prevent consumer confusion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.